CF
RVNC

Corebridge Financial’s Revance Therapeutics, Inc. RVNC Stock Holding History

Corebridge Financial’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-51,761
Closed -$157K – 3035
2024
Q4 		$157K Sell
51,761
-3,907
-7% -$11.9K ﹤0.01% 2312
2024
Q3 		$289K Sell
55,668
-343
-0.6% -$1.78K ﹤0.01% 2015
2024
Q2 		$144K Buy
+56,011
New +$144K ﹤0.01% 2389